KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
118 hedge funds and large institutions have $439M invested in Keryx Biopharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 47 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Holders
118
Holding in Top 10
–
Calls
$5.35M
Puts
$4.62M
Top Buyers
| 1 | +$6.52M | |
| 2 | +$4.38M | |
| 3 | +$3.73M | |
| 4 |
Goldman Sachs
New York
|
+$2.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$881K |
Top Sellers
| 1 | -$3.95M | |
| 2 | -$3.31M | |
| 3 | -$2.66M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.12M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$1.85M |